What is the address of DR. VAN REUSEL- DR. MICHELS?

The registered office of DR. VAN REUSEL- DR. MICHELS is located at Paleisstraat 51, 2018 Antwerpen.

Is DR. VAN REUSEL- DR. MICHELS still active?

Yes. According to the CBE (7 October 2026) DR. VAN REUSEL- DR. MICHELS is active, legal situation “Normale toestand”, started on 31 July 2007.

Is DR. VAN REUSEL- DR. MICHELS registered on Peppol?

Yes, DR. VAN REUSEL- DR. MICHELS is registered on the Peppol network with ID 0208:0891156024.

What is the enterprise number of DR. VAN REUSEL- DR. MICHELS?

The enterprise number of DR. VAN REUSEL- DR. MICHELS is BE0891156024.

When was DR. VAN REUSEL- DR. MICHELS founded?

DR. VAN REUSEL- DR. MICHELS was founded on 31 July 2007.

Who are the directors of DR. VAN REUSEL- DR. MICHELS?

According to the 2025 annual accounts, the directors of DR. VAN REUSEL- DR. MICHELS are: Raf Van Reusel, Sofie Michels.

Is DR. VAN REUSEL- DR. MICHELS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 July 2007; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. VAN REUSEL- DR. MICHELS make in 2025?

DR. VAN REUSEL- DR. MICHELS posted a profit after taxes of € 155,956 in financial year 2025.

What is the revenue of DR. VAN REUSEL- DR. MICHELS?

As a small company, DR. VAN REUSEL- DR. MICHELS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 277,806.

DR. VAN REUSEL- DR. MICHELS (Private Limited) - Antwerpen

Dossier DR. VAN REUSEL- DR. MICHELS, printed on 7 October 2026 from databakkes.be/en/0891156024/dr-van-reusel-dr-michels. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VAN REUSEL- DR. MICHELS from Antwerpen, company number BE0891156024, closed financial year 2025 with a result of € 155,956 after tax. For that financial year DR. VAN REUSEL- DR. MICHELS recorded a gross margin of € 277,806 and equity of € 475,550. Compared with financial year 2024, the result moved from € 100,300 to € 155,956. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 475,550

▲ 49% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 155,956

▲ 55% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,925

▲ 113% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 463,150.

People and assets in 2025

Vehicles and equipment

€ 3,572

▼ 62% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 511,936

▼ 8% vs 2024

€ 33,494 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 20,092

▲ 105% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 46,650

▲ € 35,960 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 333,388 Revenue 2024: € 333,388 First fiscal year in the series	-
Gross margin	€ 125,503 Gross margin 2022: € 125,503 First fiscal year in the series	€ 169,787 Gross margin 2023: € 169,787 ▲ 35% vs 2022 (€ 125,503) Favourable step	€ 213,408 Gross margin 2024: € 213,408 ▲ 26% vs 2023 (€ 169,787) Favourable step	€ 277,806 Gross margin 2025: € 277,806 ▲ 30% vs 2024 (€ 213,408) Favourable step	▲ 30%
Profit after taxes	€ 41,689 Profit after taxes 2022: € 41,689 First fiscal year in the series	€ 70,465 Profit after taxes 2023: € 70,465 ▲ 69% vs 2022 (€ 41,689) Favourable step	€ 100,300 Profit after taxes 2024: € 100,300 ▲ 42% vs 2023 (€ 70,465) Favourable step	€ 155,956 Profit after taxes 2025: € 155,956 ▲ 55% vs 2024 (€ 100,300) Favourable step	▲ 55%
Equity	€ 354,060 Equity 2022: € 354,060 First fiscal year in the series	€ 410,191 Equity 2023: € 410,191 ▲ 16% vs 2022 (€ 354,060) Favourable step	€ 319,594 Equity 2024: € 319,594 ▼ 22% vs 2023 (€ 410,191) Unfavourable step	€ 475,550 Equity 2025: € 475,550 ▲ 49% vs 2024 (€ 319,594) Favourable step	▲ 49%
Total debts	€ 693,182 Total debts 2022: € 693,182 First fiscal year in the series	€ 622,611 Total debts 2023: € 622,611 ▼ 10% vs 2022 (€ 693,182) Favourable step	€ 769,709 Total debts 2024: € 769,709 ▲ 24% vs 2023 (€ 622,611) Unfavourable step	€ 580,150 Total debts 2025: € 580,150 ▼ 25% vs 2024 (€ 769,709) Favourable step	▼ 25%
Cash	€ 20,247 Cash 2022: € 20,247 First fiscal year in the series	€ 2,367 Cash 2023: € 2,367 ▼ 88% vs 2022 (€ 20,247) Unfavourable step	€ 80,868 Cash 2024: € 80,868 ▲ € 78,500 vs 2023 (€ 2,367) Favourable step	€ 171,925 Cash 2025: € 171,925 ▲ 113% vs 2024 (€ 80,868) Favourable step	▲ 113%
Land & buildings	€ 12,893 Land & buildings 2022: € 12,893 First fiscal year in the series	€ 11,522 Land & buildings 2023: € 11,522 ▼ 11% vs 2022 (€ 12,893) Unchanged	€ 10,150 Land & buildings 2024: € 10,150 ▼ 12% vs 2023 (€ 11,522) Unchanged	€ 8,779 Land & buildings 2025: € 8,779 ▼ 14% vs 2024 (€ 10,150) Unchanged	▼ 14%
Retained profit	€ 341,660 Retained profit 2022: € 341,660 First fiscal year in the series	€ 397,791 Retained profit 2023: € 397,791 ▲ 16% vs 2022 (€ 341,660) Favourable step	€ 307,194 Retained profit 2024: € 307,194 ▼ 23% vs 2023 (€ 397,791) Unfavourable step	€ 463,150 Retained profit 2025: € 463,150 ▲ 51% vs 2024 (€ 307,194) Favourable step	▲ 51%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 14,334 Dividend 2023: € 14,334 ▲ € 12,734 vs 2022 (€ 1,600) Unchanged	€ 190,896 Dividend 2024: € 190,896 ▲ € 176,562 vs 2023 (€ 14,334) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 190,896) Unchanged	▼ 100%
Bank debt	€ 648,947 Bank debt 2022: € 648,947 First fiscal year in the series	€ 605,989 Bank debt 2023: € 605,989 ▼ 7% vs 2022 (€ 648,947) Favourable step	€ 555,194 Bank debt 2024: € 555,194 ▼ 8% vs 2023 (€ 605,989) Favourable step	€ 511,936 Bank debt 2025: € 511,936 ▼ 8% vs 2024 (€ 555,194) Favourable step	▼ 8%
Balance sheet total	€ 1,047,242 Balance sheet total 2022: € 1,047,242 First fiscal year in the series	€ 1,032,802 Balance sheet total 2023: € 1,032,802 ▼ 1% vs 2022 (€ 1,047,242) Unchanged	€ 1,089,303 Balance sheet total 2024: € 1,089,303 ▲ 5% vs 2023 (€ 1,032,802) Unchanged	€ 1,055,700 Balance sheet total 2025: € 1,055,700 ▼ 3% vs 2024 (€ 1,089,303) Unchanged	▼ 3%

Key figures of DR. VAN REUSEL- DR. MICHELS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VAN REUSEL- DR. MICHELS?

What happened at DR. VAN REUSEL- DR. MICHELS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 155,956 (▲ 55% vs 2024). Source: NBB ↗
2015 Sofie Michels became a director. NBB
Jul 31, 2007 New establishment in Antwerpen. KBO
Jul 31, 2007 Start of the company according to the CBE. KBO
2007 Raf Van Reusel became a director. NBB

In short

From € 41,689 profit in 2022 to € 155,956 profit in 2025.

Paid € 164,943 in corporate taxes since 2022.

Best year ever: 2025, with € 155,956 profit.

Paid out € 206,830 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VAN REUSEL- DR. MICHELS? We notify you, reason included.

Follow DR. VAN REUSEL- DR. MICHELS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Raf Van Reusel Sofie Michels

UROLOGIE KEMPEN

DR. VAN REUSEL- DR. MICHELS

Behind DR. VAN REUSEL- DR. MICHELS are Raf Van Reusel and Sofie Michels. Raf Van Reusel is also behind UROLOGIE KEMPEN.

See the full network in the app

Directors

According to the 2025 annual accounts

Raf Van Reusel

Director

Also active at: UROLOGIE KEMPEN

since 2007

Sofie Michels

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Paleisstraat 51

2018 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0891.156.024
VAT number: BE 0891.156.024
Registered office: Paleisstraat 51, 2018 Antwerpen
Names & denominations: DR. VAN REUSEL- DR. MICHELS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 July 2007
Peppol: Active · Active since 1 Jan 2001
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗